New VAERS 2 0 Website and updated vaccine adverse event reporting from @CDCgov & @FDA & bit.ly/VAERS2
Higher heart risk seen with Abbott dissolving stent after two years: study whtc.com/news/articles/2017/…
MedWatcher retweeted
Why did it take 20 years to learn that a surgical tool used on women could spread cancer? nyti.ms/2kuvGg7
MedWatcher retweeted
New paper! Looking for early signals in social media collaborative research with @UMCGlobalSafety @US_FDA @BoozAllen bit.ly/2krnBvS
Exciting insights! xitter.cf/epidemico/status/81854…
Can Twitter & Facebook be used to detect safety
signals for medical products? bit.ly/2iVNNLK @DrugSafetyJour
An effective Ebola vaccine - incredible news as we head into 2017! n.pr/2hi1FT3
Chantix, Zyban Lose Boxed Warning on Psych Effects medpagetoday.com/PrimaryCare…
FDA says yes to new ecstasy trials as relief for PTSD patients nyti.ms/2gGv4mn
FDA outlines data needed for over-the-counter sunscreen additives fxn.ws/2gezenA
FDA approves Prasterone for dyspareunia in postmenopausal women wb.md/2fD50u7
FDA delays experimental arthritis drug, sarilumab, over manufacturing concerns bit.ly/2f6OORO
FDA issues new labels for prescription testosterone products bit.ly/2f7zk19
#UberHealth is back! Awesome opportunity for flu vaccination thanks to @johnbrownstein, @epidemico and @Uber. newsroom.uber.com/uber-for-h…
MedWatcher retweeted
3 groundbreaking projects the White House #CancerMoonshot is pursuing bit.ly/2ehlEvY
Homeopathic teething products could be linked to 10 infant deaths, says FDA bit.ly/2egcCj6
FDA commissioner calls for retraction of Sarepta drug study bit.ly/2dpvTBf @statnews
Controversial muscular dystrophy drug approved by FDA nbcnews.to/2ckg8vk






